Zentalis Pharmaceuticals, Inc. Common Stock

ZNTLNASDAQUSD
4.04 USD
0.25 (6.60%)AT CLOSE (11:59 AM EDT)
4.04
0.00 (0.05%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
4.04
0.00 (0.05%)
🔴Market: CLOSED

Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) is currently trading at $4.04. ZNTL shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 26, 2026.

Open?$3.75
High?$4.07
Low?$3.68
Prev. Close?$3.79
Volume?7.5M
Avg. Volume?1.2M
VWAP?$3.87
Rel. Volume?6.22x
Bid / Ask
Bid?$4.02 × 100
Ask?$4.06 × 100
Spread?$0.04
Midpoint?$4.04
Valuation & Ratios
Market Cap?287.6M
Shares Out?71.2M
Float?46.7M
Float %?64.6%
P/E Ratio?N/A
P/B Ratio?1.57
EPS?-$1.74
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Employees
106
Market Cap
269.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-04-03
Address
10275 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
Phone: (858) 263-4333
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
40
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.36Distress
Confidence?56%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.67%High
Short Interest?5.0M
Days to Cover?5.6
Free Float46.7M
Avg Daily Volume883.2K
Settlement Date2026-06-15
Financial Health
Current Ratio?6.19Strong
Quick Ratio?6.19Strong
Cash Ratio?0.91Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
85
1.57CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.8CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-68.0%WEAK
ROA?
S&P
3
-49.1%WEAK
Cash Flow & Enterprise
FCF?$-125601000
Enterprise Value?$255.7M
Fundamentals ratios updated end of day